2024 Q2 Form 10-K Financial Statement

#000107023524000057 Filed on April 04, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $144.0M $173.0M $853.0M
YoY Change -61.39% 14.57% 30.03%
Cost Of Revenue $48.00M $44.00M $333.0M
YoY Change -75.26% -13.73% 40.51%
Gross Profit $96.00M $129.0M $520.0M
YoY Change -46.37% 29.0% 24.11%
Gross Profit Margin 66.67% 74.57% 60.96%
Selling, General & Admin $78.00M $150.0M $323.0M
YoY Change -21.21% 89.87% -5.0%
% of Gross Profit 81.25% 116.28% 62.12%
Research & Development $42.00M $38.00M $178.0M
YoY Change -22.22% -15.56% -14.01%
% of Gross Profit 43.75% 29.46% 34.23%
Depreciation & Amortization $13.00M $13.00M $59.00M
YoY Change -18.75% -35.0% -43.81%
% of Gross Profit 13.54% 10.08% 11.35%
Operating Expenses $135.0M $126.0M $558.0M
YoY Change -28.95% 8.62% -51.22%
Operating Profit -$39.00M $3.000M -$38.00M
YoY Change 254.55% -118.75% -94.76%
Interest Expense $5.000M $4.000M $19.00M
YoY Change 66.67% -33.33% 280.0%
% of Operating Profit 133.33%
Other Income/Expense, Net
YoY Change
Pretax Income -$34.00M -$52.00M -$106.0M
YoY Change 325.0% -89.45% -85.28%
Income Tax $8.000M $4.000M $24.00M
% Of Pretax Income
Net Earnings -$42.00M -$56.00M -$130.0M
YoY Change 281.82% -88.69% -82.29%
Net Earnings / Revenue -29.17% -32.37% -15.24%
Basic Earnings Per Share -$0.07 -$0.22
Diluted Earnings Per Share -$0.07 -$0.10 -$0.22
COMMON SHARES
Basic Shares Outstanding 589.2M shares 584.5M shares
Diluted Shares Outstanding 584.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $229.0M $237.0M $237.0M
YoY Change -55.62% -44.37% -44.37%
Cash & Equivalents $143.0M $175.0M $175.0M
Short-Term Investments $86.00M $62.00M $62.00M
Other Short-Term Assets $57.00M $47.00M $47.00M
YoY Change 9.62% -74.18% -74.18%
Inventory
Prepaid Expenses
Receivables $148.0M $199.0M $199.0M
Other Receivables $24.00M $25.00M $25.00M
Total Short-Term Assets $458.0M $508.0M $508.0M
YoY Change -34.2% -31.63% -31.63%
LONG-TERM ASSETS
Property, Plant & Equipment $19.00M $53.00M $53.00M
YoY Change -20.83% 112.0% -23.19%
Goodwill $561.0M $562.0M
YoY Change -5.87% -5.55%
Intangibles
YoY Change
Long-Term Investments $37.00M $36.00M $36.00M
YoY Change 5.71% 5.88% 5.88%
Other Assets $59.00M $82.00M $82.00M
YoY Change -1.67% 925.0% 134.29%
Total Long-Term Assets $865.0M $887.0M $887.0M
YoY Change -11.55% -5.24% -5.24%
TOTAL ASSETS
Total Short-Term Assets $458.0M $508.0M $508.0M
Total Long-Term Assets $865.0M $887.0M $887.0M
Total Assets $1.323B $1.395B $1.395B
YoY Change -20.97% -16.91% -16.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.000M $17.00M $17.00M
YoY Change -71.43% -29.17% -29.17%
Accrued Expenses $112.0M $117.0M $117.0M
YoY Change -12.5% -18.18% -18.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $321.0M $356.0M $356.0M
YoY Change -56.39% -51.17% -51.17%
LONG-TERM LIABILITIES
Long-Term Debt $194.0M $194.0M $194.0M
YoY Change
Other Long-Term Liabilities $1.000M $69.00M $69.00M
YoY Change 0.0% 6800.0% -25.81%
Total Long-Term Liabilities $1.000M $263.0M $263.0M
YoY Change 0.0% 26200.0% 182.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $321.0M $356.0M $356.0M
Total Long-Term Liabilities $1.000M $263.0M $263.0M
Total Liabilities $581.0M $619.0M $619.0M
YoY Change -28.71% -24.7% -24.7%
SHAREHOLDERS EQUITY
Retained Earnings -$2.200B -$2.158B
YoY Change 7.9% 6.41%
Common Stock $2.957B $2.948B
YoY Change 1.27% 1.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $742.0M $776.0M $776.0M
YoY Change
Total Liabilities & Shareholders Equity $1.323B $1.395B $1.395B
YoY Change -20.97% -16.91% -16.91%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$42.00M -$56.00M -$130.0M
YoY Change 281.82% -88.69% -82.29%
Depreciation, Depletion And Amortization $13.00M $13.00M $59.00M
YoY Change -18.75% -35.0% -43.81%
Cash From Operating Activities -$15.00M -$15.00M -$3.000M
YoY Change -115.15% 50.0% -98.86%
INVESTING ACTIVITIES
Capital Expenditures $1.000M $4.000M $21.00M
YoY Change -50.0% -66.67% 200.0%
Acquisitions
YoY Change
Other Investing Activities -$24.00M -$62.00M $67.00M
YoY Change -14.29% -200.0% -69.12%
Cash From Investing Activities -$26.00M -$66.00M $46.00M
YoY Change -31.58% -232.0% -73.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.000M $6.000M
YoY Change 0.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.000M 46.00M -165.0M
YoY Change -50.0% -2850.0%
NET CHANGE
Cash From Operating Activities -$15.00M -15.00M -3.000M
Cash From Investing Activities -$26.00M -66.00M 46.00M
Cash From Financing Activities $1.000M 46.00M -165.0M
Net Change In Cash -$40.00M -35.00M -122.0M
YoY Change -163.49% -187.5% 45.24%
FREE CASH FLOW
Cash From Operating Activities -$15.00M -$15.00M -$3.000M
Capital Expenditures $1.000M $4.000M $21.00M
Free Cash Flow -$16.00M -$19.00M -$24.00M
YoY Change -116.49% -13.64% -91.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175000000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
62000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6000000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
199000000 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
21000000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
47000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
508000000 usd
CY2024Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
25000000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
36000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
57000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
203000000 usd
CY2024Q1 us-gaap Assets
Assets
1395000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
17000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
117000000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
28000000 usd
CY2024Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
0 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
194000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
356000000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
28000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3000000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
619000000 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
589232539 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2948000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2158000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
776000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1395000000 usd
CY2023 us-gaap Revenues
Revenues
656000000 usd
CY2022 us-gaap Revenues
Revenues
718000000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
237000000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
251000000 usd
CY2023 us-gaap Gross Profit
GrossProfit
419000000 usd
CY2022 us-gaap Gross Profit
GrossProfit
467000000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
207000000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219000000 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54000000 usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
35000000 usd
CY2024 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2024 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-3000000 usd
CY2024 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
645000000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-125000000 usd
CY2024 us-gaap Investment Income Net
InvestmentIncomeNet
19000000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106000000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-130000000 usd
CY2024 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1000000 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000000 usd
CY2024 us-gaap Repayments Of Debt
RepaymentsOfDebt
515000000 usd
CY2024 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
344000000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-165000000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-122000000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12000000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
367000000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
175000000 usd
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-02-29
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001070235
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-29
CY2024 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2024 bbry Term Subscription Contract Duration
TermSubscriptionContractDuration
P4Y
CY2024 bbry Software Maintenance Revenue Term Io T
SoftwareMaintenanceRevenueTermIoT
P1Y
CY2024 bbry Share Based Compensation Arrangement By Share Based Payment Award Other Than Stock Options Award Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanStockOptionsAwardVestingPeriod
P3Y
CY2024Q1 bbry Number Of Endpoints Secured Vehicles
NumberOfEndpointsSecuredVehicles
235000000 endpoint
CY2024 bbry Tbrsu Share Limit
TBRSUShareLimit
1 shares
CY2024 bbry Pbrsu Share Limit
PBRSUShareLimit
1.5 shares
CY2024 us-gaap Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration
RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GeneralAndAdministrativeExpense
CY2024Q1 bbry Interest Rate To Present Value Long Term Restructuring Liability
InterestRateToPresentValueLongTermRestructuringLiability
0.050
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
3200000000 usd
CY2023Q3 dei Entity Public Float
EntityPublicFloat
3200000000 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
589233606 shares
CY2024 dei Auditor Firm
AuditorFirmId
271
CY2024 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2024 dei Auditor Location
AuditorLocation
Toronto, Canada
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
131000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120000000 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
12000000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
182000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
743000000 usd
CY2023Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
27000000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
34000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
154000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
562000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
595000000 usd
CY2023Q1 us-gaap Assets
Assets
1679000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
143000000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
20000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
729000000 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
194000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
822000000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
589232539 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2909000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2028000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-24000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
857000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1679000000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1504000000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000000 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-734000000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
857000000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-130000000 usd
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33000000 usd
CY2024 bbry Stock Issued During Period Value Deferred Shared Unit
StockIssuedDuringPeriodValueDeferredSharedUnit
1000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
776000000 usd
CY2024 us-gaap Revenues
Revenues
853000000 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
333000000 usd
CY2024 us-gaap Gross Profit
GrossProfit
520000000 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
186000000 usd
CY2024 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
171000000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176000000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
183000000 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
181000000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
164000000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114000000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
165000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
15000000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
138000000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
212000000 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2022 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1144000000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
469000000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-725000000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2000000 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
5000000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
21000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-720000000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-130000000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-734000000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 usd
CY2024 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1000000 usd
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2024 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
6000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
2000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
1000000 usd
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000000 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-120000000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-739000000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6000000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-130000000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-734000000 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
59000000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105000000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176000000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
33000000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
34000000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
36000000 usd
CY2024 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2023 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2022 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
22000000 usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
35000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
15000000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024 bbry Intellectual Property Disposed Of By Sale
IntellectualPropertyDisposedOfBySale
147000000 usd
CY2023 bbry Intellectual Property Disposed Of By Sale
IntellectualPropertyDisposedOfBySale
0 usd
CY2022 bbry Intellectual Property Disposed Of By Sale
IntellectualPropertyDisposedOfBySale
0 usd
CY2024 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
6000000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-3000000 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
138000000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
212000000 usd
CY2024 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
13000000 usd
CY2023 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
16000000 usd
CY2022 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
16000000 usd
CY2024 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
79000000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18000000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44000000 usd
CY2024 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
9000000 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-13000000 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2024 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1000000 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-6000000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1000000 usd
CY2024 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
53000000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-15000000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7000000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2000000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2000000 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21000000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11000000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-16000000 usd
CY2024 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8000000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9000000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5000000 usd
CY2024 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7000000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-29000000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-50000000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3000000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-263000000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28000000 usd
CY2024 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
2000000 usd
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
3000000 usd
CY2022 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
1000000 usd
CY2024 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
0 usd
CY2023 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
0 usd
CY2022 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
35000000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000000 usd
CY2024 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31000000 usd
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
514000000 usd
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
916000000 usd
CY2024 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
CY2023 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
CY2022 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
24000000 usd
CY2024 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
223000000 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
717000000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1104000000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46000000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
176000000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
207000000 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6000000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000000 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-84000000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
188000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406000000 usd
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements requires management to make estimates and assumptions with respect to the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. Significant areas requiring the use of management estimates relate to revenue-related estimates including variable consideration, standalone selling price (“SSP”), estimated customer life, right of return and customer incentive commitments, fair value of reporting units in relation to actual or potential goodwill impairment, fair value of the Debentures (as defined in Note 6), fair value of share-based liability awards, fair value of long-lived assets in relation to actual or potential impairment, the Company’s long-lived asset groupings, estimated useful lives of property, plant and equipment and intangible assets, provision (or recovery) of income taxes, realization of deferred income tax assets and the related components of the valuation allowance, allowance for credit losses, incremental borrowing rates in determining the present value of lease liabilities and the determination of reserves for various litigation claims. Actual results could differ from these estimates, which were based upon circumstances that existed as of the date of the consolidated financial statements, February 29, 2024.</span></div>
CY2024 bbry Rs Usforfeitedsettledincashorsoldtocoverwithholdingtaxrequirementscountedas
RSUsforfeitedsettledincashorsoldtocoverwithholdingtaxrequirementscountedas
1 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8000000 shares
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2024 bbry Liability For Uncertain Tax Positions Percentage Minimum
LiabilityForUncertainTaxPositionsPercentageMinimum
0.50
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
45875000 shares
CY2024 bbry Shares Issuedas Options Number Counted
SharesIssuedasOptionsNumberCounted
0.625 shares
CY2024 bbry Tbrsu Share Limit
TBRSUShareLimit
1 shares
CY2024 bbry Pbrsu Share Limit
PBRSUShareLimit
1.5 shares
CY2024 bbry Options Forfeited Numberof Shares Counted
OptionsForfeitedNumberofSharesCounted
0.625 shares
CY2024 bbry Investments That Are Communicated To Third Party For Consideration Of Reasonableness Threshold Limit For Fair Value
InvestmentsThatAreCommunicatedToThirdPartyForConsiderationOfReasonablenessThresholdLimitForFairValue
0.005
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
35000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
7000000 usd
CY2024Q1 bbry Patent Abandonment Cost
PatentAbandonmentCost
15000000 usd
CY2024Q1 bbry Patent Abandonment Accumulated Amortization
PatentAbandonmentAccumulatedAmortization
7000000 usd
CY2024 bbry Patent Abandonment Classified As Impairment Of Lla Net Book Value
PatentAbandonmentClassifiedAsImpairmentOfLLANetBookValue
8000000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2023 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
4000000 usd
CY2022 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
0 usd
CY2024Q1 bbry Cash Cash Equivalents And Investments At Cost
CashCashEquivalentsAndInvestmentsAtCost
302000000 usd
CY2024 bbry Cash Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsAndInvestmentsUnrealizedGains
6000000 usd
CY2024 bbry Cash Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsAndInvestmentsUnrealizedLosses
-10000000 usd
CY2024Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
298000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175000000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
62000000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
36000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
25000000 usd
CY2023Q1 bbry Cash Cash Equivalents And Investments At Cost
CashCashEquivalentsAndInvestmentsAtCost
491000000 usd
CY2023 bbry Cash Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsAndInvestmentsUnrealizedGains
6000000 usd
CY2023 bbry Cash Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsAndInvestmentsUnrealizedLosses
-10000000 usd
CY2023Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
487000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
131000000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
34000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
27000000 usd
CY2024Q1 bbry Equity Investmentwithout Readily Determinable Fair Value
EquityInvestmentwithoutReadilyDeterminableFairValue
36000000 usd
CY2023Q1 bbry Equity Investmentwithout Readily Determinable Fair Value
EquityInvestmentwithoutReadilyDeterminableFairValue
34000000 usd
CY2024 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
3000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
3000000 usd
CY2022 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
35000000 usd
CY2022 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
13000000 usd
CY2022 bbry Realized Gains Losses On Non Marketable Equity Investments Without Readily Determinable Fair Value Sold During The Period
RealizedGainsLossesOnNonMarketableEquityInvestmentsWithoutReadilyDeterminableFairValueSoldDuringThePeriod
22000000 usd
CY2024 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295000000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
25000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
27000000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
28000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
166000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
166000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
364000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
364000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
10000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
0 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
10000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
0 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
176000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
166000000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
374000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
364000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1000000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1000000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1000000 usd
CY2024 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
5000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6000000 usd
CY2024Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Cecl Estimated Based On Days Past Due And Region
AccountsReceivableAllowanceForCreditLossRelatingToCECLEstimatedBasedOnDaysPastDueAndRegion
1000000 usd
CY2023Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Cecl Estimated Based On Days Past Due And Region
AccountsReceivableAllowanceForCreditLossRelatingToCECLEstimatedBasedOnDaysPastDueAndRegion
1000000 usd
CY2024Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Customers Evaluated Separately
AccountsReceivableAllowanceForCreditLossRelatingToCustomersEvaluatedSeparately
5000000 usd
CY2023Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Customers Evaluated Separately
AccountsReceivableAllowanceForCreditLossRelatingToCustomersEvaluatedSeparately
0 usd
CY2024Q1 bbry Numberof Customers Witha Balance Greaterthan10of Total Accounts Receivable
NumberofCustomersWithaBalanceGreaterthan10ofTotalAccountsReceivable
2
CY2023Q1 bbry Numberof Customers Witha Balance Greaterthan10of Total Accounts Receivable
NumberofCustomersWithaBalanceGreaterthan10ofTotalAccountsReceivable
2
CY2023 bbry Other Receivables Greater Than Five Percent Of Current Assets
OtherReceivablesGreaterThanFivePercentOfCurrentAssets
0 numberofotherreceivables
CY2024 bbry Other Receivables Greater Than Five Percent Of Current Assets
OtherReceivablesGreaterThanFivePercentOfCurrentAssets
0 numberofotherreceivables
CY2024Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
0 usd
CY2023Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
141000000 usd
CY2024Q1 bbry Other Current Assets Other Amounts
OtherCurrentAssetsOtherAmounts
47000000 usd
CY2023Q1 bbry Other Current Assets Other Amounts
OtherCurrentAssetsOtherAmounts
41000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
47000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
182000000 usd
CY2024 bbry Revenue Recognized On Patent Sale
RevenueRecognizedOnPatentSale
218000000 usd
CY2024 bbry Intellectual Property Disposed Of By Sale
IntellectualPropertyDisposedOfBySale
147000000 usd
CY2023Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
141000000 usd
CY2024 bbry Patent Maintenance On Intellectual Property Sold
PatentMaintenanceOnIntellectualPropertySold
6000000 usd
CY2023 bbry Other Current Assets Greaterthanfivepercentof Current Assets
OtherCurrentAssetsGreaterthanfivepercentofCurrentAssets
0 other_current_asset
CY2024 bbry Other Current Assets Greaterthanfivepercentof Current Assets
OtherCurrentAssetsGreaterthanfivepercentofCurrentAssets
0 other_current_asset
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
109000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
114000000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
88000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
89000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25000000 usd
CY2024 us-gaap Depreciation
Depreciation
10000000 usd
CY2023 us-gaap Depreciation
Depreciation
12000000 usd
CY2022 us-gaap Depreciation
Depreciation
15000000 usd
CY2024 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 usd
CY2023Q1 bbry Cost Of Property Plant And Equipment Net Sold
CostOfPropertyPlantAndEquipmentNetSold
29000000 usd
CY2023Q1 bbry Accumulated Amortization Of Property Plant And Equipment Net Sold
AccumulatedAmortizationOfPropertyPlantAndEquipmentNetSold
18000000 usd
CY2023Q1 bbry Nbv Of Property Plant And Equipment Net Sold
NBVOfPropertyPlantAndEquipmentNetSold
11000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1397000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1243000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
154000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1409000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1206000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
203000000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
49000000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93000000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
161000000 usd
CY2024 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
14000000 usd
CY2023 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
34000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
42000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
36000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
31000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
18000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
6000000 usd
CY2021Q1 us-gaap Goodwill
Goodwill
849000000 usd
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-5000000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
844000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2023 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-4000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
595000000 usd
CY2024 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
2000000 usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
35000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
562000000 usd
CY2024 bbry Other Long Term Assets Greater Than Five Percent Of Total Assets
OtherLongTermAssetsGreaterThanFivePercentOfTotalAssets
0 numberofotherlong-termassets
CY2023 bbry Other Long Term Assets Greater Than Five Percent Of Total Assets
OtherLongTermAssetsGreaterThanFivePercentOfTotalAssets
0 numberofotherlong-termassets
CY2024Q1 bbry Operating Lease Liabilities Current Included In Accruals
OperatingLeaseLiabilitiesCurrentIncludedInAccruals
20000000 usd
CY2023Q1 bbry Operating Lease Liabilities Current Included In Accruals
OperatingLeaseLiabilitiesCurrentIncludedInAccruals
24000000 usd
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
20000000 usd
CY2023Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
77000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
116000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
117000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
143000000 usd
CY2023 bbry Other Accrued Liabilities Greaterthan Five Percentof Current Liabilities
OtherAccruedLiabilitiesGreaterthanFivePercentofCurrentLiabilities
0 numberofaccruedliabilities
CY2024 bbry Other Accrued Liabilities Greaterthan Five Percentof Current Liabilities
OtherAccruedLiabilitiesGreaterthanFivePercentofCurrentLiabilities
0 numberofaccruedliabilities
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2023 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
10000000 usd
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
7000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
3000000 usd
CY2024 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
37000000 usd
CY2024 us-gaap Payments For Restructuring
PaymentsForRestructuring
19000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
21000000 usd
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
20000000 usd
CY2024Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
1000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
21000000 usd
CY2024Q1 bbry Interest Rate To Present Value Long Term Restructuring Liability
InterestRateToPresentValueLongTermRestructuringLiability
0.050
CY2024 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
37000000 usd
CY2023 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
10000000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-28000000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-191000000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5000000 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
28000000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
125000000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9000000 usd
CY2024 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
11000000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
10000000 usd
CY2022 bbry Effective Income Tax Rate Reconciliation Tax Credit Owing Investment Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOwingInvestmentAmount
7000000 usd
CY2024 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1000000 usd
CY2023 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
1000000 usd
CY2022 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-2000000 usd
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
4000000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
10000000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000000 usd
CY2024 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
8000000 usd
CY2023 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
5000000 usd
CY2022 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
3000000 usd
CY2024 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
9000000 usd
CY2023 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
65000000 usd
CY2022 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
0 usd
CY2024 bbry Effective Income Tax Rate Reconciliation Prior Period Adjustment
EffectiveIncomeTaxRateReconciliationPriorPeriodAdjustment
9000000 usd
CY2023 bbry Effective Income Tax Rate Reconciliation Prior Period Adjustment
EffectiveIncomeTaxRateReconciliationPriorPeriodAdjustment
4000000 usd
CY2022 bbry Effective Income Tax Rate Reconciliation Prior Period Adjustment
EffectiveIncomeTaxRateReconciliationPriorPeriodAdjustment
-1000000 usd
CY2024 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
6000000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
5000000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-18000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-128000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
133000000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-88000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-592000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-114000000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-720000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19000000 usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2000000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1000000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1000000 usd
CY2024 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
22000000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
13000000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
8000000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
258000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
264000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
37000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
44000000 usd
CY2024Q1 bbry Minimum Taxes
MinimumTaxes
207000000 usd
CY2023Q1 bbry Minimum Taxes
MinimumTaxes
207000000 usd
CY2024Q1 bbry Deferred Tax Assets Convertible Debentures
DeferredTaxAssetsConvertibleDebentures
0 usd
CY2023Q1 bbry Deferred Tax Assets Convertible Debentures
DeferredTaxAssetsConvertibleDebentures
1000000 usd
CY2024Q1 bbry Deferred Tax Assets Researchand Development
DeferredTaxAssetsResearchandDevelopment
402000000 usd
CY2023Q1 bbry Deferred Tax Assets Researchand Development
DeferredTaxAssetsResearchandDevelopment
390000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
514000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
495000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
125000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
122000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1543000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1523000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1520000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1492000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
31000000 usd
CY2024Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
23000000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
31000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
23000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
31000000 usd
CY2024Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
28000000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
125000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1520000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1492000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21000000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24000000 usd
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
2000000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
4000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21000000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2024Q1 bbry Unrecognizedtaxbenefitsnettedagainstdeferredincometaxes
Unrecognizedtaxbenefitsnettedagainstdeferredincometaxes
20000000 usd
CY2024Q1 bbry Unrecognizedtaxbenefitsincludedwithintaxespayable
Unrecognizedtaxbenefitsincludedwithintaxespayable
0 usd
CY2024Q1 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
0 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1952000000 usd
CY2024Q1 bbry Researchanddevelopmenttaxcredit
Researchanddevelopmenttaxcredit
496000000 usd
CY2024Q1 bbry Minimum Taxes
MinimumTaxes
207000000 usd
CY2024 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
0 usd
CY2024 us-gaap Interest Expense Debt
InterestExpenseDebt
6000000 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
6000000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
6000000 usd
CY2024 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
51500000 shares
CY2024 bbry Value Of Deferred Share Units Redeemed For Shares
ValueOfDeferredShareUnitsRedeemedForShares
1000000 usd
CY2024 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-130000000 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-734000000 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
12000000 usd
CY2024 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
0 usd
CY2023 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
138000000 usd
CY2022 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
212000000 usd
CY2024 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
0 usd
CY2023 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
6000000 usd
CY2022 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
6000000 usd
CY2024 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-130000000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-866000000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-194000000 usd
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
584543000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
578654000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
570607000 shares
CY2024 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
60833000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
60833000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
584543000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
639487000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
631440000 shares
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
25000000 usd
CY2024Q1 bbry Funds From Claim Filed With Ministry Of Innovation Science And Economic Development Canada Relating To Strategic Innovation Fund Program
FundsFromClaimFiledWithMinistryOfInnovationScienceAndEconomicDevelopmentCanadaRelatingToStrategicInnovationFundProgram
17000000 usd
CY2023Q1 bbry Funds From Claim Filed With Ministry Of Innovation Science And Economic Development Canada Relating To Strategic Innovation Fund Program
FundsFromClaimFiledWithMinistryOfInnovationScienceAndEconomicDevelopmentCanadaRelatingToStrategicInnovationFundProgram
17000000 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2023Q3 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1000000 usd
CY2023Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
164000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2024 us-gaap Lessor Operating Lease Option To Terminate
LessorOperatingLeaseOptionToTerminate
one month
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
18000000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
20000000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
23000000 usd
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
28000000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
32000000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
37000000 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13000000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15000000 usd
CY2024 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
13000000 usd
CY2023 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
15000000 usd
CY2023 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
15000000 usd
CY2024 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
7000000 usd
CY2023 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
4000000 usd
CY2022 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
0 usd
CY2024 us-gaap Sublease Income
SubleaseIncome
4000000 usd
CY2023 us-gaap Sublease Income
SubleaseIncome
3000000 usd
CY2022 us-gaap Sublease Income
SubleaseIncome
3000000 usd
CY2024 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52000000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
58000000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
76000000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
23000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
65000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7000000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
58000000 usd
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
186000000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
207000000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219000000 usd
CY2024 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
171000000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176000000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
183000000 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
181000000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
164000000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114000000 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54000000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
165000000 usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
15000000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
35000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2024 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-3000000 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
138000000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
212000000 usd
CY2024 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2022 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-720000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19000000 usd
CY2023Q2 bbry Patent Sale Cash Consideration On Closing
PatentSaleCashConsiderationOnClosing
170000000 usd
CY2023Q2 bbry Patent Sale Consideration No Later Than Third Anniversary Date Of Closing
PatentSaleConsiderationNoLaterThanThirdAnniversaryDateOfClosing
30000000 usd
CY2023Q2 bbry Patent Sale Consideration In The Form Of Potential Future Royalty
PatentSaleConsiderationInTheFormOfPotentialFutureRoyalty
700000000 usd
CY2024 bbry Revenue Recognized On Patent Sale
RevenueRecognizedOnPatentSale
218000000 usd
CY2024 bbry Intellectual Property Disposed Of By Sale
IntellectualPropertyDisposedOfBySale
147000000 usd
CY2024Q1 bbry Patent Sale Financing Component
PatentSaleFinancingComponent
10000000 usd
CY2024 bbry Patent Sale Variable Consideration Recognized On Sale
PatentSaleVariableConsiderationRecognizedOnSale
23000000 usd
CY2024 bbry Patent Sale Variable Consideration Constrained
PatentSaleVariableConsiderationConstrained
210000000 usd
CY2024 us-gaap Revenues
Revenues
853000000 usd
CY2024 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2023 us-gaap Revenues
Revenues
656000000 usd
CY2023 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2022 us-gaap Revenues
Revenues
718000000 usd
CY2022 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2024 us-gaap Revenues
Revenues
853000000 usd
CY2023 us-gaap Revenues
Revenues
656000000 usd
CY2022 us-gaap Revenues
Revenues
718000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
222000000 usd
CY2024 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
12000000 usd
CY2023 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1000000 usd
CY2022 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1000000 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
769000000 usd
CY2024Q1 us-gaap Assets
Assets
1395000000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
867000000 usd
CY2023Q1 us-gaap Assets
Assets
1679000000 usd
CY2024 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2023 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2022 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2024 us-gaap Interest Paid Net
InterestPaidNet
6000000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
6000000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
6000000 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000000 usd
CY2024 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
1000000 usd
CY2023 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
5000000 usd
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
6000000 usd
CY2024 us-gaap Advertising Expense
AdvertisingExpense
22000000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
29000000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
25000000 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
0 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
0 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1000000 usd
CY2024Q1 bbry Percentage Of Cash And Cash Equivalents Denominated In Foreign Currencies
PercentageOfCashAndCashEquivalentsDenominatedInForeignCurrencies
0.19
CY2024Q1 bbry Percentage Of Accounts Receivable Denominated In Foreign Currencies
PercentageOfAccountsReceivableDenominatedInForeignCurrencies
0.25
CY2024Q1 bbry Percentage Of Accrued Liabilities Denominated In Foreign Currencies
PercentageOfAccruedLiabilitiesDenominatedInForeignCurrencies
0.59
CY2023Q1 bbry Percentage Of Cash And Cash Equivalents Denominated In Foreign Currencies
PercentageOfCashAndCashEquivalentsDenominatedInForeignCurrencies
0.19
CY2023Q1 bbry Percentage Of Accounts Receivable Denominated In Foreign Currencies
PercentageOfAccountsReceivableDenominatedInForeignCurrencies
0.24
CY2023Q1 bbry Percentage Of Accrued Liabilities Denominated In Foreign Currencies
PercentageOfAccruedLiabilitiesDenominatedInForeignCurrencies
0.36
CY2024 bbry Percent Of Cash Equivalents And Investments Threshold Used To Determine Major Issuers
PercentOfCashEquivalentsAndInvestmentsThresholdUsedToDetermineMajorIssuers
0.30
CY2023 bbry Percent Of Cash Equivalents And Investments Threshold Used To Determine Major Issuers
PercentOfCashEquivalentsAndInvestmentsThresholdUsedToDetermineMajorIssuers
0.12
CY2024Q1 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
0 usd
CY2023Q1 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
1000000 usd
CY2024Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
298000000 usd

Files In Submission

Name View Source Status
0001070235-24-000057-index-headers.html Edgar Link pending
0001070235-24-000057-index.html Edgar Link pending
0001070235-24-000057.txt Edgar Link pending
0001070235-24-000057-xbrl.zip Edgar Link pending
a2013equityincentiveplan.htm Edgar Link pending
a2013equityincentiveplan001.jpg Edgar Link pending
a2013equityincentiveplan002.jpg Edgar Link pending
a2013equityincentiveplan003.jpg Edgar Link pending
a2013equityincentiveplan004.jpg Edgar Link pending
a2013equityincentiveplan005.jpg Edgar Link pending
a2013equityincentiveplan006.jpg Edgar Link pending
a2013equityincentiveplan007.jpg Edgar Link pending
a2013equityincentiveplan008.jpg Edgar Link pending
a2013equityincentiveplan009.jpg Edgar Link pending
a2013equityincentiveplan010.jpg Edgar Link pending
a2013equityincentiveplan011.jpg Edgar Link pending
a2013equityincentiveplan012.jpg Edgar Link pending
a2013equityincentiveplan013.jpg Edgar Link pending
a2013equityincentiveplan014.jpg Edgar Link pending
a2013equityincentiveplan015.jpg Edgar Link pending
a2013equityincentiveplan016.jpg Edgar Link pending
a2013equityincentiveplan017.jpg Edgar Link pending
a2013equityincentiveplan018.jpg Edgar Link pending
a2013equityincentiveplan019.jpg Edgar Link pending
a2013equityincentiveplan020.jpg Edgar Link pending
a2013equityincentiveplan021.jpg Edgar Link pending
a2013equityincentiveplan022.jpg Edgar Link pending
a2013equityincentiveplan023.jpg Edgar Link pending
a2013equityincentiveplan024.jpg Edgar Link pending
a2013equityincentiveplan025.jpg Edgar Link pending
a2013equityincentiveplan026.jpg Edgar Link pending
bb-02292024x10kexhibit231.htm Edgar Link pending
bb-02292024x10kexhibit311.htm Edgar Link pending
bb-02292024x10kexhibit312.htm Edgar Link pending
bb-02292024x10kexhibit321.htm Edgar Link pending
bb-02292024x10kexhibit322.htm Edgar Link pending
bbry-20240229.htm Edgar Link pending
bbry-20240229.xsd Edgar Link pending
bbry-20240229_g1.jpg Edgar Link pending
clawbackpolicyblackberry.htm Edgar Link pending
clawbackpolicyblackberry001.jpg Edgar Link pending
clawbackpolicyblackberry002.jpg Edgar Link pending
clawbackpolicyblackberry003.jpg Edgar Link pending
exhibit21-bbsubsidiariesfe.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
philkurtz-employmentagmt.htm Edgar Link pending
philkurtz-employmentagmt001.jpg Edgar Link pending
philkurtz-employmentagmt002.jpg Edgar Link pending
philkurtz-employmentagmt003.jpg Edgar Link pending
philkurtz-employmentagmt004.jpg Edgar Link pending
philkurtz-employmentagmt005.jpg Edgar Link pending
philkurtz-employmentagmt006.jpg Edgar Link pending
philkurtz-employmentagmt007.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
bbry-20240229_def.xml Edgar Link unprocessable
bbry-20240229_lab.xml Edgar Link unprocessable
bbry-20240229_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bbry-20240229_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bbry-20240229_cal.xml Edgar Link unprocessable